Furthermore, Ahrens and colleagues identified an association between increased methylation at a CpG site (cg11669516) in the first intron and reduced expression of insulin-like growth factor binding protein 2 (igfbp2) gene in NAFLD and NASH patients [82]. Here, IGFBP2 is linked to metabolic dysfunction-associated steatohepatitis.